Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency

4-phenylbutyrate (PB) and structurally related compounds hold promise for treating many diseases, including cancers. However, pharmaceutical limitations, such as an unpleasant taste or poor aqueous solubility, impede their evaluation and clinical use. This study explores cyclodextrin (CD) complexati...

Full description

Bibliographic Details
Main Authors: Kindness L. Commey, Akari Nakatake, Airi Enaka, Ryota Nakamura, Koji Nishi, Kenji Tsukigawa, Hirohito Ikeda, Koki Yamaguchi, Daisuke Iohara, Fumitoshi Hirayama, Keishi Yamasaki, Masaki Otagiri
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/20/15091
_version_ 1797573680088219648
author Kindness L. Commey
Akari Nakatake
Airi Enaka
Ryota Nakamura
Koji Nishi
Kenji Tsukigawa
Hirohito Ikeda
Koki Yamaguchi
Daisuke Iohara
Fumitoshi Hirayama
Keishi Yamasaki
Masaki Otagiri
author_facet Kindness L. Commey
Akari Nakatake
Airi Enaka
Ryota Nakamura
Koji Nishi
Kenji Tsukigawa
Hirohito Ikeda
Koki Yamaguchi
Daisuke Iohara
Fumitoshi Hirayama
Keishi Yamasaki
Masaki Otagiri
author_sort Kindness L. Commey
collection DOAJ
description 4-phenylbutyrate (PB) and structurally related compounds hold promise for treating many diseases, including cancers. However, pharmaceutical limitations, such as an unpleasant taste or poor aqueous solubility, impede their evaluation and clinical use. This study explores cyclodextrin (CD) complexation as a strategy to address these limitations. The structural chemistry of the CD complexes of these compounds was analyzed using phase solubility, nuclear magnetic resonance (NMR) spectroscopic techniques, and molecular modeling to inform the choice of CD for such application. The study revealed that PB and its shorter-chain derivative form 1:1 αCD complexes, while the longer-chain derivatives form 1:2 (guest:host) complexes. αCD includes the alkyl chain of the shorter-chain compounds, depositing the phenyl ring around its secondary rim, whereas two αCD molecules sandwich the phenyl ring in a secondary-to-secondary rim orientation for the longer-chain derivatives. βCD includes each compound to form 1:1 complexes, with their alkyl chains bent to varying degrees within the CD cavity. γCD includes two molecules of each compound to form 2:1 complexes, with both parallel and antiparallel orientations plausible. The study found that αCD is more suitable for overcoming the pharmaceutical drawbacks of PB and its shorter-chain derivative, while βCD is better for the longer-chain derivatives.
first_indexed 2024-03-10T21:12:30Z
format Article
id doaj.art-2859208fb89746b3823f4ef019660ac5
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T21:12:30Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2859208fb89746b3823f4ef019660ac52023-11-19T16:41:29ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-10-0124201509110.3390/ijms242015091Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size DependencyKindness L. Commey0Akari Nakatake1Airi Enaka2Ryota Nakamura3Koji Nishi4Kenji Tsukigawa5Hirohito Ikeda6Koki Yamaguchi7Daisuke Iohara8Fumitoshi Hirayama9Keishi Yamasaki10Masaki Otagiri11Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Jonan-ku, Fukuoka 814-0180, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, JapanFaculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan4-phenylbutyrate (PB) and structurally related compounds hold promise for treating many diseases, including cancers. However, pharmaceutical limitations, such as an unpleasant taste or poor aqueous solubility, impede their evaluation and clinical use. This study explores cyclodextrin (CD) complexation as a strategy to address these limitations. The structural chemistry of the CD complexes of these compounds was analyzed using phase solubility, nuclear magnetic resonance (NMR) spectroscopic techniques, and molecular modeling to inform the choice of CD for such application. The study revealed that PB and its shorter-chain derivative form 1:1 αCD complexes, while the longer-chain derivatives form 1:2 (guest:host) complexes. αCD includes the alkyl chain of the shorter-chain compounds, depositing the phenyl ring around its secondary rim, whereas two αCD molecules sandwich the phenyl ring in a secondary-to-secondary rim orientation for the longer-chain derivatives. βCD includes each compound to form 1:1 complexes, with their alkyl chains bent to varying degrees within the CD cavity. γCD includes two molecules of each compound to form 2:1 complexes, with both parallel and antiparallel orientations plausible. The study found that αCD is more suitable for overcoming the pharmaceutical drawbacks of PB and its shorter-chain derivative, while βCD is better for the longer-chain derivatives.https://www.mdpi.com/1422-0067/24/20/15091cyclodextrins4-phenylbutyrateinclusion complexationstructural chemistryinclusion modecavity size dependency
spellingShingle Kindness L. Commey
Akari Nakatake
Airi Enaka
Ryota Nakamura
Koji Nishi
Kenji Tsukigawa
Hirohito Ikeda
Koki Yamaguchi
Daisuke Iohara
Fumitoshi Hirayama
Keishi Yamasaki
Masaki Otagiri
Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency
International Journal of Molecular Sciences
cyclodextrins
4-phenylbutyrate
inclusion complexation
structural chemistry
inclusion mode
cavity size dependency
title Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency
title_full Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency
title_fullStr Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency
title_full_unstemmed Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency
title_short Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency
title_sort study of the structural chemistry of the inclusion complexation of 4 phenylbutyrate and related compounds with cyclodextrins in solution differences in inclusion mode with cavity size dependency
topic cyclodextrins
4-phenylbutyrate
inclusion complexation
structural chemistry
inclusion mode
cavity size dependency
url https://www.mdpi.com/1422-0067/24/20/15091
work_keys_str_mv AT kindnesslcommey studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT akarinakatake studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT airienaka studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT ryotanakamura studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT kojinishi studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT kenjitsukigawa studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT hirohitoikeda studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT kokiyamaguchi studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT daisukeiohara studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT fumitoshihirayama studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT keishiyamasaki studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency
AT masakiotagiri studyofthestructuralchemistryoftheinclusioncomplexationof4phenylbutyrateandrelatedcompoundswithcyclodextrinsinsolutiondifferencesininclusionmodewithcavitysizedependency